ECSP003601A - PROTEINS DERIVED FROM THE MANCHA BLANCA SYNDROME VIRUS AND ITS USES - Google Patents

PROTEINS DERIVED FROM THE MANCHA BLANCA SYNDROME VIRUS AND ITS USES

Info

Publication number
ECSP003601A
ECSP003601A ECSP003601A ECSP003601A EC SP003601 A ECSP003601 A EC SP003601A EC SP003601 A ECSP003601 A EC SP003601A EC SP003601 A ECSP003601 A EC SP003601A
Authority
EC
Ecuador
Prior art keywords
kda
syndrome virus
proteins
proteins derived
mancha
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Hulten Maria Cornelia Wilhelmia Van
Justinus Maria Vlak
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003601 priority Critical patent/ECSP003601A/en
Publication of ECSP003601A publication Critical patent/ECSP003601A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere al aislamiento y caracterización de cuatro importantes proteínas derivadas del virus del sindrome de mancha blanca (WSSV) con un tamaño estimado de 28 kDa (VP26), 26 kDa (VP26), 24 kDa(VP24) y 19 kDa (VP19) y uso uso en la elaboración de una vacuna para proteger a los crustáceos contra infecciones de WSSV. La invención además proporciona secuencias nucleotidas las que codifican a estas proteínas y su uso en la producción recombinante de las mismas. Adicionalmente, la invención proporciona anticuerpos creados contra dichas proteínas, su uso en la vacunación pasiva y equipos de diagnóstico que contiene ácidos nucleicos y anticuerpos.The present invention relates to the isolation and characterization of four important proteins derived from white spot syndrome virus (WSSV) with an estimated size of 28 kDa (VP26), 26 kDa (VP26), 24 kDa (VP24) and 19 kDa ( VP19) and use use in the development of a vaccine to protect crustaceans against WSSV infections. The invention further provides nucleotide sequences that encode these proteins and their use in recombinant production thereof. Additionally, the invention provides antibodies created against such proteins, their use in passive vaccination, and diagnostic kits containing nucleic acids and antibodies.

ECSP003601 2000-08-02 2000-08-02 PROTEINS DERIVED FROM THE MANCHA BLANCA SYNDROME VIRUS AND ITS USES ECSP003601A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003601 ECSP003601A (en) 2000-08-02 2000-08-02 PROTEINS DERIVED FROM THE MANCHA BLANCA SYNDROME VIRUS AND ITS USES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003601 ECSP003601A (en) 2000-08-02 2000-08-02 PROTEINS DERIVED FROM THE MANCHA BLANCA SYNDROME VIRUS AND ITS USES

Publications (1)

Publication Number Publication Date
ECSP003601A true ECSP003601A (en) 2000-11-24

Family

ID=42041208

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003601 ECSP003601A (en) 2000-08-02 2000-08-02 PROTEINS DERIVED FROM THE MANCHA BLANCA SYNDROME VIRUS AND ITS USES

Country Status (1)

Country Link
EC (1) ECSP003601A (en)

Similar Documents

Publication Publication Date Title
ES2505695T3 (en) Immunogenic compositions for Streptococcus pyogenes
ECSP093601A (en) PROTEINS DERIVED FROM THE WHITE SPOT SYNDROME VIRUS AND ITS USES
ES2129386T1 (en) INFLUENZA VACCINE.
EA200900784A1 (en) VACCINES INCLUDING ANTIGENS FROM FOUR STRAINS OF THE INFLUENZA VIRUS
DE60121136D1 (en) Proteasome-INFLUENZA VIRUS VACCINE COMPOSITION
AR071220A1 (en) ASTROVIRUS AVIARIO DEPOSITED UNDER THE NUERO CNCM I-3895
PE20011217A1 (en) PHARMACEUTICAL COMPOSITION FOR IMMUNOLOGICAL MODULATION AND VACCINE PREPARATION
BRPI0208301B8 (en) isolated nucleic acid, and composition
ECSP024257A (en) OLD PROTEINS OF THE VIRUS DISEASE OF THE WHITE SPOT DISEASE IN THE SHRIMP AND USES OF THE SAME
ATE426412T1 (en) ADJUVANT INFLUENZA VACCINE
ECSP066495A (en) COMPOSITIONS AND METHODS TO INHIBIT INFECTION BY WHITE POINT SYNDROME VIRUS (WSSV)
SE8701413D0 (en) EXPRESSION AND PURIFICATION OF AN HTLV-III GAG / ENV GENE PROTEIN
AR068507A1 (en) CONSTRUCTIONS VECTOR FLUOROCARBONADO-ANTIGENO FOR THE SUPPLY OF ANTIGENS IFLUENZA
NO20062044L (en) Piscirickettsia salmonis antigens and their use
CY1117746T1 (en) Influenza hematopoietic antigens and corresponding DNA fragments
ES2144399T3 (en) CLONING THE CHICKEN ANEMIA VIRUS DNA.
ES2561483T3 (en) GAS57 mutant antigens and GAS57 antibodies
ECSP003601A (en) PROTEINS DERIVED FROM THE MANCHA BLANCA SYNDROME VIRUS AND ITS USES
EE200200157A (en) The vaccine
DE69633919D1 (en) MULTIPURPOSE VACCINE AGAINST ENVIRONED VIRUSES
BR112023022367A2 (en) ANTI-TIGIT ANTIBODIES AND METHODS OF USE THEREOF
AR022662A1 (en) NUCLEIC ACIDS AND PROTEINS OF THE MYCOPLASMA HYOPNEUMONIAE GEN MHP3 AND ITS USES
ECSP11010772A (en) INFECTION INHIBITOR
AR248047A1 (en) Vaccines based on modified bovine herpesvirus type i
AR034771A1 (en) VACCINATION FORMULATION POTENTIATED BY THE COMBINATION OF A DNA WITH AN ANTIGEN